Commonwealth Biotechnologies, Inc. has agreed to acquire privately owned GL Biochem (Shanghai) Ltd., a manufacturer of peptide products and reagents. In 2008, GL Biochem produced $13 million of revenue and $2 million of net income, representing a compound annual growth rate of 40%. In an all-stock transaction, CBI will issue 6.56 million shares to owners of GL Biochem, which will give them 51% ownership of CBI. More details...

Stock Symbol: (NSDQ: CBTE)